Pradip De
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
- Oncology 23
- HER2/EGFR in Cancer Research 9
- Cancer Cells and Metastasis 6
- Cancer-related Molecular Pathways 6
-
- Cancer Genomics and Diagnostics 8
- Co-authors
- Nandini DeyBrian Leyland‐JonesCasey WilliamsJennifer C. AskeJennifer CarlsonRazelle KurzrockShumei KatoScott M. Lippman
- Journals
- International Journal of Molecular Sciences (3 papers)Cancers (3 papers)Cancer Treatment Reviews (2 papers)Journal of Clinical Oncology (2 papers)Oncotarget (2 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Pradip De
36 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 596
- Oncology 988
- Molecular Biology 1.0k
- Pulmonary and Respiratory Medicine 438
- Pathology and Forensic Medicine 220
Countries citing papers authored by Pradip De
This map shows the geographic impact of Pradip De's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pradip De with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pradip De more than expected).
Fields of papers citing papers by Pradip De
This network shows the impact of papers produced by Pradip De. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pradip De. The network helps show where Pradip De may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pradip De, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 24 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 2 | |
| 6 | 2021 | 36 | |
| 7 | 2021 | 62 | |
| 8 | The trastuzumab era: current and upcoming targeted HER2+ breast cancer therapies. | 2020 | 129 |
| 9 | 2020 | 24 | |
| 10 | Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study Hit paper breakdown → | 2019 | 429 |
| 11 | 2018 | 10 | |
| 12 | 2017 | 90 | |
| 13 | 2017 | 33 | |
| 14 | Promise of Precision Medicine in Cancers: Lessons Learned. | 2017 | 1 |
| 15 | 2015 | 16 | |
| 16 | 2014 | 87 | |
| 17 | 2013 | 215 | |
| 18 | 2013 | 8 | |
| 19 | 2013 | 61 | |
| 20 | 2002 | 64 |
About Pradip De
Pradip De is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 36 papers that have together received 2.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Cancer Genomics and Diagnostics (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Cells and Metastasis (6 papers), Cancer-related Molecular Pathways (6 papers), Genetic factors in colorectal cancer (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Cancer Research (596 citations), Oncology (988 citations), Molecular Biology (1.0k citations), Pulmonary and Respiratory Medicine (438 citations) and Pathology and Forensic Medicine (220 citations). Pradip De has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Nandini Dey, Brian Leyland‐Jones, Casey Williams, Jennifer C. Aske, Jennifer Carlson, Razelle Kurzrock, Shumei Kato, Scott M. Lippman, Jeffrey S. Ross and J. Jack Lee. Their work appears in journals such as International Journal of Molecular Sciences, Cancers, Cancer Treatment Reviews, Journal of Clinical Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.